Financial Daily from THE HINDU group of publications
Sunday, Apr 30, 2006
Financial Daily from THE HINDU group of publications Sunday, Apr 30, 2006 |
|
|
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Suven Life net doubles Our Bureau
Hyderabad , April 29
Suven Life Sciences Ltd has registered a growth of 36 per cent in turnover, while its net profit doubled during the financial year ended March 2006. As per the unaudited financial results, the turnover stood at Rs 82.93 crore against Rs 60.77 crore in the previous year, while the net profit amounted to Rs 7.64 crore (Rs 3.8 crore), yielding an EPS of Rs 3.06 (Rs 1.52) on shares of Rs 2 face value. In a press release, the company said it spent 20 per cent of its revenue on R&D during the year, which is yielding good results in intellectual property creation. The company has filed 32 product patents so far. Further, it is in final phases of filing first Investigational New Drug (IND) application with the US Food and Drug Administration during this year in the therapeutic area of CNS focusing on Alzheimer's disease, an unmet medical need, the release said.
More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|